In cerebrospinal fluid of healthy controls, subjective cognitive decline (SCD), mild cognitive impairment (MCI), and AD, soluble TREM2 was increased in SCD, while MCP-1 was noted at the MCI and AD stages [258]. This evidence concerns the gene TREM2 and Alzheimer disease.